Insights On Upstream Manufacturing
-
Game-Changing CLD Platforms: Strategies, Technologies, Workflows
10/21/2025
Selecting the right cell line platform is complex. Learn how flexible strategies, integrated technologies, and expert workflows enable high productivity, rapid timelines, and a de-risked path to clinical success.
-
Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.
10/20/2025
In this episode of "Better Biopharma," host Tyler Menichiello is joined by MindImmune's president and CEO, Stevin Zorn, Ph.D. They discuss the development of the company's lead candidate, MITI-101, a monoclonal antibody designed to prevent peripheral immune cells from entering the brain and driving neuroinflammation linked to Alzheimer's disease.
-
Predicting The Performance Of Perfusion Media In A Continuous Bioreactor
10/17/2025
Small-scale perfusion-mimic models can effectively predict media performance in continuous bioreactors to help optimize cell density, productivity, and scalability for CHO cell lines.
-
Simplify Process Scale-Up With An Innovative Single-Use Bioreactor
10/15/2025
Consistent cell growth and protein yields from 5 L to 5,000 L show how a unified bioreactor design can simplify scale-up, reduce risk, and accelerate upstream process development in bioproduction.
-
Centrifuge Bioprocess Bags: Closed, Sterile Cell Harvest, And Separation
10/15/2025
Explore single-use centrifuge bags designed for efficient cell harvest and separation that offer robust film technology, full traceability, and seamless integration with Sorvall BIOS 16 systems.
-
Break The Cell Therapy Manufacturing Bottleneck With Day-0 Transduction, Day-3 Harvest
10/14/2025
Discover the potential of T1 cell-derived nanoparticles (CDNPs) to accelerate T-cell activation. See how CDNPs’ unique mechanism of mimicking physiological immune stimulation positions them for broad use.
-
High-Throughput Screening For High-Performance Cell Culture Media Development
10/14/2025
Learn about a high-throughput screening method that successfully optimized cell culture media, leading to a greater than 3-fold improvement in viral genome titer for AAV2 production.
-
Advanced Approaches For Developing And Optimizing Perfusion Platforms
10/14/2025
Discover how to effectively use small-scale perfusion-mimic systems to identify optimal cell culture media and significantly increase volumetric productivity for large-scale biomanufacturing.
-
Cell Bank And Scale Up Strategies For MSC And Exosome Manufacturing
10/9/2025
Discover how effective cell banking and scale-up strategies can reduce risk and cost in advanced therapy manufacturing. Learn practical ways to meet increasing cell and exosome quantity needs.
-
Redefining T Cell Culture Media
10/6/2025
Media selection is key to CAR-T cell success. Learn how a serum-free, xeno-free medium boosts transduction efficiency, maintains quality, and streamlines the path to clinical scale-up.